The Effect of Intracervical Lidocaine Injection Versus Topical Lidocaine Gel on the Pain Experienced by Patients Undergoing Tenaculum Application to the Cervix at the Time of an Office Gynecologic Procedure
Overview
- Phase
- Phase 4
- Intervention
- Intracervical Lidocaine Injection
- Conditions
- Cervical Pain
- Sponsor
- Oregon Health and Science University
- Enrollment
- 74
- Locations
- 1
- Primary Endpoint
- Tenaculum Pain
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The purpose of this clinical trial is to evaluate the effect of an intracervical lidocaine injection versus topical lidocaine gel on the pain experienced by patients undergoing tenaculum application to the cervix during office gynecologic procedures. This study will also evaluate how satisfied women are with the method of pain control used.
The researchers hypothesize that:
- There is less pain perceived by patients undergoing placement of a tenaculum on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.
- Patients are more satisfied with pain control during the overall experience of undergoing tenaculum placement on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.
Detailed Description
Subjects who have already scheduled an IUD insertion or endometrial biopsy will be asked to join this study assessing two pain control interventions at the time of tenaculum application to the cervix during office gynecologic procedures. Only healthy women ages 18 and over with an indication for endometrial biopsy or IUD placement will be recruited. The participants will be randomized to one of two arms: an intracervical lidocaine injection versus topical lidocaine gel. They will be asked to indicate their level of pain and level of satisfaction using a Visual Analog Scale. The primary outcome, pain with tenaculum placement, and the secondary outcome, satisfaction with the experience of tenaculum placement, will be compared between the study groups.
Investigators
Paula Bednarek
MD MPH
Oregon Health and Science University
Eligibility Criteria
Inclusion Criteria
- •Generally healthy women
- •Age 18 and over
- •Indication for endometrial biopsy or IUD placement
Exclusion Criteria
- •Allergy to lidocaine or other local anesthetic
- •Pregnancy, known or suspected
- •Patients who are premedicated with misoprostol
- •Patients with a chronic pain condition for which the patient takes daily pain medication
Arms & Interventions
Intracervical Lidocaine Injection
Injection of 2 cc of 1% lidocaine solution at the anterior lip of the cervix using a standard 22 gauge spinal needle.
Intervention: Intracervical Lidocaine Injection
Topical Lidocaine Gel
Application of 1cc of 2% lidocaine gel to the anterior lip of the cervix with a Q-tip (this amount of lidocaine will be measured out prior to procedure)
Intervention: Topical Lidocaine Gel
Outcomes
Primary Outcomes
Tenaculum Pain
Time Frame: After tenaculum placement
The primary outcome was pain at the time of tenaculum placement. Patient asked to pain scale using 100mm Visual Analog Scale (0mm=no pain, 100mm=worst pain of my life) during after tenaculum placement.
Secondary Outcomes
- Tenaculum Placement Satisfaction(After placement of the tenaculum)
- Intervention Pain(after application of randomized intervention)